MaxCyte Appoints Douglas Swirsky as Chief Financial Officer

ROCKVILLE, Md., March 27, 2023 -- MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization... | March 27, 2023

Related Keywords

United Kingdom , Douglasj Swirsky , Mary Jane Elliott , Ron Holtz , David Deuchler , Rupert Dearden , Panmure Gordon , Chris Welsh , Doug Doerfler , Douglas Swirsky , Emma Earl Freddy Crossley , Board Of Cellectar Biosciences Inc , Aavantibio Inc , Exchange Commission On , Maxcyte Inc , Nasdaq , Consilium Strategic Communications , Rexahn Pharmaceuticals Inc , Gilmartin Group , Morgan Stanley , Business Administration , Linkedin , Legg Mason , Twitter , Solid Biosciences Inc , Genvec Inc , Administration For The Company , Exchange Commission , Kellogg School Of Management At Northwestern University , Boston University , Chief Financial Officer , Solid Biosciences , Interim President , Chief Executive Officer , Rexahn Pharmaceuticals , Chief Financial , Managing Director , Life Sciences Investment Banking , Stifel Nicolaus , Cellectar Biosciences , Kellogg School , Chief Accounting Officer , Private Securities Litigation Reform Act , Annual Report , Cyte Contacts , Joint Corporate , Maxcyte , Nc Stock Exchange , News , Information , Press Release , Arch , 023 , Ocused , Company , Roviding , Nabling , Platform , Technologies , O , Advance , The , Development , Nd Mxct Us57777k1060 ,